JASPER THERAPEUTICS
Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
JASPER THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2018-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.jaspertherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
415-946-1087
Email Addresses:
[email protected]
Total Funding:
149.1 M USD
Technology used in webpage:
Euro Microsoft Exchange Online Office 365 Mail IPv6 Gravity Forms WP Engine Zendesk Mimecast Akamai Hosted Zoom Video Conferencing
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Evox Therapeutics
Evox Therapeutics is a biotechnology company that harnesses and engineer the natural trafficking capabilities of extracellular vesicles.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Velan Capital
Velan Capital investment in Post-IPO Equity - Jasper Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Post-IPO Equity - Jasper Therapeutics
Woodline Partners
Woodline Partners investment in Post-IPO Equity - Jasper Therapeutics
Roche Venture Fund
Roche Venture Fund investment in Post-IPO Equity - Jasper Therapeutics
Avego Healthcare Capital
Avego Healthcare Capital investment in Post-IPO Equity - Jasper Therapeutics
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Post-IPO Equity - Jasper Therapeutics
Abingworth
Abingworth investment in Post-IPO Equity - Jasper Therapeutics
Amgen
Amgen investment in Post-IPO Equity - Jasper Therapeutics
Kingdon Capital
Kingdon Capital investment in Post-IPO Equity - Jasper Therapeutics
Apeiron Investment Group
Apeiron Investment Group investment in Post-IPO Equity - Jasper Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-28 | Jasper Therapeutics Announces Appointment of Ronald Martell as Chief Executive OfficerWilliam Lis to Continue as Chairman, Board of Directors |
Official Site Inspections
http://www.jaspertherapeutics.com Semrush global rank: 4.07 M Semrush visits lastest month: 3.01 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
